Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-18

Clinical Trial Update: Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how L-thyroxine replacement affects serum lipids and atherosclerosis in hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Thyroxine (levothyroxine)

Snippet

Sponsor: Shandong Provincial Hospital | Conditions: Hypothyroidism, Thyroid Diseases | Phase 4 | Status: UNKNOWN